Patents Assigned to C.Y.L. Pharmazeutika GmbH
  • Agent having a destructive effect on malignant tumors and method for the production thereof
    Patent number: 7855191
    Abstract: Disclosed is an agent which has a destructive effect on malignant tumors and contains alpha-ketoglutaric acid, N-acetyl-seleno-L-methionine, N-acetyl-L-methionine, and a compound that is capable of forming azomethine and is selected among the group 5-hydroxymethylfurfural, dehydroascorbic acid, maltol, and vanillin as an active substance, 5-hydroxymethylfurfural being preferred. The inventive agent can be used in the form of an infusion, in an oral or rectal form of administration, or as an irrigation in cancer therapy.
    Type: Grant
    Filed: October 13, 2003
    Date of Patent: December 21, 2010
    Assignees: C.Y.L. Pharmazeutika GmbH
    Inventors: Karl Groke, Ilse Groke, legal representative, Veronika Groke, legal representative, Paul Groke, legal representative, Ralf Herwig, Peter Ferdinand